Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 8, 2023. (Total: 223870Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 4 (of 4 Records)

Query Trace: Abdominal Pain and CYP2C19[original query]
Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: a 1-week, randomized, open-label study in Chinese adults.
Clinical therapeutics 2010 Nov 32 (12): 2003-11.
Pan Xiaolin, Li Yuqing, Qiu Yuping, Tang Qiyun, Qian Bingbing, Yao Linhua, Shi Ruihua, Zhang Guox
A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors.
Investigational new drugs 2016 Dec .
Kyriakopoulos Christos E, Braden Amy M, Kolesar Jill M, Eickhoff Jens C, Bailey Howard H, Heideman Jennifer, Liu Glenn, Wisinski Kari
Association of CYP2C19 Polymorphism With Proton Pump Inhibitors Effectiveness and With Fractures in Real-Life: Retrospective Cohort Study.
Clinical pharmacology and therapeutics 2022 Feb .
Gronich Naomi, Lavi Idit, Lejbkowicz Flavio, Pinchev Mila, Rennert G
[The relationship between genetic polymorphism of CYP2C19 and the efficacy of Helicobacter pylori eradication therapy in children].
Zhonghua er ke za zhi = Chinese journal of pediatrics 2023 6 61 (7): 600-605.
L L Luo, B Chen, X L Shu, W Zheng, G Long, M Z Jia
TOP